Press Release
IMGENEX India awarded BIRAC Phase II grant to develop biosimilar Herceptin for breast cancer
IMGENEX India received a 3-year Phase II grant under the BIRAC scheme of the Government of India to develop biosimilar Herceptin (Trastuzumab) for the treatment of breast cancer.
Read more